The effect of a gastric bypass procedure on the pharmacokinetics of citalopram

The effect of a gastric bypass procedure on the pharmacokinetics of citalopram - CITA study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON57704

Enrollment

Registered

2013-04-15

Start date

2014-04-10

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bariatrische chirurgie depression gastric bypass

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The participant is on the waiting list for gastric bypass surgery and using oral citalopram whithout changes in dosages for at last three months.

Exclusion criteria

Exclusion criteria: Persons who previously have undergone bariatric surgery.

Design outcomes

Primary

Measure	Time frame
Main study parameters / endpoints: AUC (area under the serum concentration-time curve) of citalopram.	—

Secondary

Measure	Time frame
Secondary study parameters / endpoints: - Outcome of depression questionnaire - Cmax (maximum serum concentration), Tmax (time of maximum serum concentration) and T1 / 2 (half-life)	—

Countries

Netherlands

Outcome results